187 related articles for article (PubMed ID: 2038782)
1. Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.
Kattan S; Collins JP; Mohr D
Urology; 1991 Jun; 37(6):516-8. PubMed ID: 2038782
[TBL] [Abstract][Full Text] [Related]
2. A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.
Sarosdy MF; Hudnall CH; Erickson DR; Hardin TC; Novicki DE
J Urol; 1989 Mar; 141(3):551-3. PubMed ID: 2645420
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Lee LM; Stevenson RW; Szasz G
J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
[TBL] [Abstract][Full Text] [Related]
4. Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.
Allen RP; Engel RM; Smolev JK; Brendler CB
J Urol; 1992 Oct; 148(4):1181-3. PubMed ID: 1404632
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 therapy for impotence, comparison with papaverine.
Earle CM; Keogh EJ; Wisniewski ZS; Tulloch AG; Lord DJ; Watters GR; Glatthaar C
J Urol; 1990 Jan; 143(1):57-9. PubMed ID: 2294263
[TBL] [Abstract][Full Text] [Related]
6. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
[TBL] [Abstract][Full Text] [Related]
7. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
Waldhauser M; Schramek P
J Urol; 1988 Sep; 140(3):525-7. PubMed ID: 3045341
[TBL] [Abstract][Full Text] [Related]
8. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
9. Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction.
Moriel EZ; Rajfer J
J Urol; 1993 May; 149(5 Pt 2):1299-300. PubMed ID: 8386779
[TBL] [Abstract][Full Text] [Related]
10. Comparative value of prostaglandin E1 and papaverine in treatment of erectile failure: double-blind crossover study among Egyptian patients.
Mahmoud KZ; el Dakhli MR; Fahmi IM; Abdel-Aziz AB
J Urol; 1992 Mar; 147(3):623-6. PubMed ID: 1538443
[TBL] [Abstract][Full Text] [Related]
11. Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy.
Zaher TF
Int Urol Nephrol; 1998; 30(2):193-6. PubMed ID: 9607891
[TBL] [Abstract][Full Text] [Related]
12. Double-blind randomized crossover study comparing intracorporeal prostaglandin E1 with combination of prostaglandin E1 and lidocaine in the treatment of organic impotence.
Kattan S
Urology; 1995 Jun; 45(6):1032-6. PubMed ID: 7771004
[TBL] [Abstract][Full Text] [Related]
13. Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence.
Katlowitz N; Albano GJ; Patsias G; Golimbu M; Morales P
Urology; 1993 Dec; 42(6):695-7. PubMed ID: 8256402
[TBL] [Abstract][Full Text] [Related]
14. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
von Heyden B; Donatucci CF; Kaula N; Lue TF
J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
[TBL] [Abstract][Full Text] [Related]
15. Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
Montorsi F; Guazzoni G; Bergamaschi F; Zucconi M; Rigatti P; Pizzini G; Miani A; Pozza G
Acta Diabetol; 1994 Apr; 31(1):1-5. PubMed ID: 8043890
[TBL] [Abstract][Full Text] [Related]
16. Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotence.
Siraj QH; Akhtar MA
J Pak Med Assoc; 1989 Jul; 39(7):172-6. PubMed ID: 2504962
[TBL] [Abstract][Full Text] [Related]
17. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
Floth A; Schramek P
J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
[TBL] [Abstract][Full Text] [Related]
18. A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence.
Wang CJ; Wu CC; Huang CH; Chiang CP
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):585-90. PubMed ID: 1296038
[TBL] [Abstract][Full Text] [Related]
19. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
Valdevenito R; Melman A
Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
[TBL] [Abstract][Full Text] [Related]
20. Use of prostaglandin E1 for papaverine-failed erections.
Reiss H
Urology; 1989 Jan; 33(1):15-6. PubMed ID: 2911923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
